Walmsley S - Search Results

1

A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.

Gillis J, Loutfy M, Bayoumi AM, Antoniou T, Burchell AN, Walmsley S, Cooper C, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg R, Raboud J; CANOC Collaboration. Gillis J, et al. Among authors: walmsley s. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):531-539. doi: 10.1097/QAI.0000000000001109. J Acquir Immune Defic Syndr. 2016. PMID: 27851713 Free PMC article.

2

Treatment with letrazuril of refractory cryptosporidial diarrhea complicating AIDS.

Loeb M, Walach C, Phillips J, Fong I, Salit I, Rachlis A, Walmsley S. Loeb M, et al. Among authors: walmsley s. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):48-53. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7648284 Clinical Trial.

3

A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome.

Walmsley S, Levinton C, Brunton J, Muradali D, Rappaport D, Bast M, Spence D, Salit I. Walmsley S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):348-57. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882099 Clinical Trial.

4

CD36 deficiency induced by antiretroviral therapy.

Serghides L, Nathoo S, Walmsley S, Kain KC. Serghides L, et al. Among authors: walmsley s. AIDS. 2002 Feb 15;16(3):353-8. doi: 10.1097/00002030-200202150-00006. AIDS. 2002. PMID: 11834946 Clinical Trial.

5

Individualized therapy for the treatment-experienced patient.

Walmsley S. Walmsley S. AIDS Read. 2003 Jun;13(6 Suppl):S11-5. AIDS Read. 2003. PMID: 12838742

6

Can structured treatment interruptions (STIs) be used as a strategy to decrease total drug requirements and toxicity in HIV infection?

Walmsley S, Loutfy M. Walmsley S, et al. J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3):95-103. doi: 10.1177/154510970200100304. J Int Assoc Physicians AIDS Care (Chic). 2002. PMID: 12942682 Review.

7

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy.

Loutfy M, Raboud J, Thompson C, Tseng A, Abdurrahman Z, Kovacs C, Rachlis A, Phillips E, Rubin G, Gough K, Walmsley S. Loutfy M, et al. Among authors: walmsley s. HIV Clin Trials. 2003 Sep-Oct;4(5):301-10. doi: 10.1310/7LYW-GQFF-WPRQ-K3QW. HIV Clin Trials. 2003. PMID: 14583846

8

Rosiglitazone for HIV-1 lipoatrophy.

Cavalcanti RB, Raboud J, Kain KC, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. Lancet. 2004 May 29;363(9423):1828-9; author reply 1829. doi: 10.1016/S0140-6736(04)16318-6. Lancet. 2004. PMID: 15172791 No abstract available.

9

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.

Cavalcanti RB, Cheung AM, Raboud J, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. J Clin Densitom. 2005 Fall;8(3):293-7. doi: 10.1385/jcd:8:3:293. J Clin Densitom. 2005. PMID: 16055959

10

Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.

Tan D, Walmsley S, Shen S, Raboud J. Tan D, et al. Among authors: walmsley s. HIV Clin Trials. 2006 May-Jun;7(3):107-15. doi: 10.1310/95VE-A6KJ-WRQ0-1F8Y. HIV Clin Trials. 2006. PMID: 16880167 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters